A Chemical Framework for Engineering Extracellular Vesicles’ Biointerface to Advance Precision Therapeutics
Advanced Materials · 2026-09 · 38 (52)
DOI: 10.1002/adma.74203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 25.07.2026. Verfasst von Leila Pourtalebi Jahromi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Department of Biology, Pharmaceutical Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Hauptthemen laut MEDLINE: Extracellular Vesicles, Precision Medicine. Die Arbeit nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCHHSTP CDC HHS, German Federal Ministry of Research, Technology, and Space, European Research Council.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are membrane‐bound nanoparticles ubiquitously secreted by all cell types and serve diverse physiological and pathological functions. Due to their pivotal roles in pathophysiological processes and their inherent biomimetic properties, EVs have attracted significant attention as biomarkers, as well as for tissue engineering and drug delivery. The surface chemistry of EVs dictates their interactions with their environment. Great strides have been made to tailor this biochemical interface with the aim of enhancing cargo delivery, target specificity, immune evasion, and tracking capabilities, while preserving EVs’ stability and functional integrity. Approaches to surface modification primarily encompass genetic and metabolic manipulation of parent cells, application of physical forces, and chemical reactions. In this manuscript, we introduce a comprehensive chemistry‐centric framework for EV surface engineering that integrates demonstrated EV modification strategies with protein‐ and cell‐surface chemistries not yet applied to EVs, delineating their functional scope and translational potential for advancing EV‐based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Science, Department of Biology, Pharmaceutical Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- FAU NeW, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
ORCID-Profile: Gregor Fuhrmann
Förderung
- NCHHSTP CDC HHS
- German Federal Ministry of Research, Technology, and Space
- European Research Council
- DATIPilot-Sprint-NAVET
Zitieren
APA
Pourtalebi Jahromi, L., Geng, F., Frenzke, J. N., & Fuhrmann, G. (2026). A Chemical Framework for Engineering Extracellular Vesicles’ Biointerface to Advance Precision Therapeutics. Advanced Materials, 38(52). https://doi.org/10.1002/adma.74203
Vancouver
Pourtalebi Jahromi L, Geng F, Frenzke JN, Fuhrmann G. A Chemical Framework for Engineering Extracellular Vesicles’ Biointerface to Advance Precision Therapeutics. Advanced Materials. 2026;38(52). doi:10.1002/adma.74203
BibTeX
@article{PourtalebiJahromi2026,
author = {Pourtalebi Jahromi, Leila and Geng, Felix and Frenzke, Jan-Noël and Fuhrmann, Gregor},
title = {A Chemical Framework for Engineering Extracellular Vesicles’ Biointerface to Advance Precision Therapeutics},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {52},
doi = {10.1002/adma.74203}
}
EUVIMED